AVEO Pharmaceuticals Investor Relations Material
Latest events
Q2 2022
AVEO Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AVEO Pharmaceuticals Inc
Access all reports
AVEO Pharmaceuticals Inc. was a biopharmaceutical company focused on the development and commercialization of oncology therapeutics. The company engaged in clinical research and regulatory advancement of targeted cancer treatments. It served healthcare providers and patients in the oncology sector. The company was headquartered in Boston, Massachusetts, and its shares were listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
AVEO
Country
🇺🇸 United States